ehealth radio network
Episodes

Thursday Oct 11, 2018
Dr. Charles Brenner on the Surprising Science of Aging
Thursday Oct 11, 2018
Thursday Oct 11, 2018
Dr. Charles Brenner, the Roy J. Carver Chair of Biochemistry at the University of Iowa and Chief Scientific Advisor at ChromaDex, the makers of TRU NIAGEN joins eHealth Radio & the Health News Channel to discuss surprising science behind aging.
Listen to interview with host Eric Michaels and guest Dr. Charles Brenner discuss the following:
What is NAD? What has your research revealed about it?
What is the relationship between NAD and aging?
What is NIAGEN, and how is it related to NAD?
Does increasing NAD levels have any other benefits, besides anti-aging? Are these potential benefits being studied in clinical studies?
Dr. Charles Brenner Dr. Charles Brenner is the Roy J. Carver Chair and Head of Biochemistry at the University of Iowa, as well as a founding co-director of the University of Iowa Obesity Initiative. In 2004, Brenner, then a faculty member at Dartmouth College, discovered nicotinamide riboside (NR) to be a vital precursor of nicotinamide adenine dinucleotide (NAD+), which is made available by nicotinamide riboside kinases (Nrks) that are conserved between yeast and humans. In 2007, Dr. Brenner's lab discovered a second pathway by which NR is converted to NAD+ and showed that NR can extend the lifespan of yeast cells by virtue of elevating NAD+ levels and increasing the activity of the NAD+ dependent Sir2 enzyme.
In the past decade, Dr. Brenner has made multiple seminal contributions to NAD+ metabolism, which include engineering a yeast strain to convert inexpensive NAD+ precursor vitamins into NR, solving the crystal structure of human Nrk1, developing the methods for quantitative NAD+ metabolomics, and demonstrating the activity of oral NR in animal models of fatty liver disease, obesity, type 2 diabetes, diabetic and chemotherapeutic neuropathy, heart failure, and central brain injury. Dr. Brenner also led the first clinical trial of NR, which established safe oral availability in humans. He is currently focusing on the maternal and neonatal effects of oral NR and translating animal discoveries into evidence-based safe, human clinical practice for human conditions of metabolic stress.
Website: www.truniagen.com | www.aboutNAD.com
Social Media Links: Facebook: https://www.facebook.com/TruNiagen Twitter: https://twitter.com/truniagen

Friday Oct 05, 2018
Friday Oct 05, 2018
Dr. Richard Toselli, CEO of the InVivo Therapeutics Corporation a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries joins eHealth Radio and the Health News & Spinal Health Channels.
Listen to interview with host Eric Michaels and guest Dr. Richard Toselli discuss the following:
Can you tell our audience about InVivo Therapeutics and what your company does?
You have an interesting background for a CEO, not a typical one. You’re a former neuro surgeon. Can you tell our audience which has an interest in healthcare and business a bit about your background and how it translates to your current role as CEO of InVivo Therapeutics?
What’s more difficult and challenging being a neuro-surgeon or the ceo of a publicly traded company haha?
You became CEO earlier this year, and reading some news on you and the company it was reported that you have made some major changes with the company under your leadership such as decreasing the cash burn rate, launching a second spinal trial. Can you discuss that and also discuss the second trial as well.
Can you talk a bit about product development with your company and how the process works so our listeners can understand.
The spinal chord industry is constantly evolving and changing. Can you chat a bit about the industry and where it’s going and where your company fits within this industry.
We know wall street is not always patient. How do companies like yours juggle the interests of investors with what you do with research and development and clinical trials etc.
Where do you see this company going in the next 3 to 5 years, what do you hope to accomplish.
Prior to joining InVivo, Dr. Toselli served as Chief Medical Officer for Cochlear Limited. In that role, he was responsible for global clinical, regulatory, and medical affairs teams reporting to the CEO. Prior to that, Dr. Toselli served five years at Sanofi in various levels of increasing responsibility, including Vice President of Global Medical Affairs – Immunology and Inflammation, Biologics Division; Vice President of Global Medical Affairs and Head of the Biosurgery Discovery Performance Unit; and Vice President of Global Medical Affairs, Biosurgery.
Before his time at Sanofi, he served as Chief Medical/Technology Officer for Covidien Surgical, and earlier held various roles at DePuy Spine including Director of Medical Affairs, Worldwide Vice President of Research and Development, and Worldwide Vice President of Clinical Evidence and External Relations. He subsequently held the position of Vice President of Evidence-Based Medicine at Johnson & Johnson for the device sector.
Dr. Toselli’s previous academic positions include Assistant Professor at Brown University, Associate Professor, Director of Spine Center, and Associate Chief of Staff at the University of North Carolina (UNC), and Associate Professor at the University of Vermont. He holds a bachelor of arts from Providence College, his medical degree from Brown University, and a masters of business administration from the UNC’s Kenan-Flagler Business School. Dr. Toselli is a board-certified neurological surgeon.
InVivo Therapeutics Holdings Corporation is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. The company was founded in 2005 with proprietary technology co-invented by Robert Langer, Sc.D., Professor at Massachusetts Institute of Technology, and Joseph P. Vacanti, M.D., who then was at Boston Children’s Hospital and who now is affiliated with Massachusetts General Hospital. In January 2018, the company announced updated clinical evidence, including improvements in patients with acute spinal cord injury (SCI), from its INSPIRE study of the Neuro-Spinal Scaffold™. The publicly traded company is headquartered in Cambridge, MA.
Website: www.invivotherapeutics.com

Thursday Oct 04, 2018
Thursday Oct 04, 2018
Aneela Idnani, Co-Founder & "Chief Trichster" at HabitAware joins eHealth Radio and the Health News & Technology Channels. She is the inspiration for HabitAware's Keen smart bracelet to help people overcome unwanted behaviors like compulsive hair pulling, skin picking and nail biting.
Listen to interview with host Eric Michaels and guest Aneela Idnani discuss the following:
Tell us a little bit about your experience with compulsive hair pulling disorder, also known as trichotillomania?
How did you come up with the idea to use technology to help you & how does the Keen bracelet work?
What resources are out there for someone who may just be realizing they have Body Focused Repetitive Behaviors?
What does recovery mean to you personally?
Can you please share one thing someone can do today to get started on their journey to BFRB awareness and recovery?
Aneela Idnani is Cofounder & President/CMO of HabitAware. HabitAware uses patented wearable technology to help people “Retrain The Brain” from detrimental behaviors to positive ones and on becoming the standard of care for debilitating mental health conditions.
Aneela is also an outspoken mental health advocate, having grown up with a common, yet relatively unknown condition called #trichotillomania (compulsive hair pulling). Aneela is a HAX hardware accelerator alumnus and her company recently received a research grant from the NIH to improve their device and validate Keen as a treatment for trichotillomania and sister disorders. Her life’s work (HabitAware) has been featured on TechCrunch, The Washington Post, Prevention Magazine and more.
Website: www.habitaware.com
Social Media Links: Facebook: www.facebook.com/habitaware Twitter: www.twitter.com/habitaware Instagram: www.instagram.com/habitaware

Wednesday Oct 03, 2018
Movement and Your Musculoskeletal Health
Wednesday Oct 03, 2018
Wednesday Oct 03, 2018
Dr. Robert Hayden, DC, PhD, a Chiropractor from Griffin, Georgia, who is also a delegate of the American Chiropractic Association joins eHealth Radio and the Chiropractic & Health News Channels. ACA represents members of the chiropractic profession nationwide and advocates for issues that are important to chiropractors and their patients.
Listen to interview with host Eric Michaels and guest Dr. Robert Hayden discuss the following:
We hear a lot about how physical activity can benefit our cardiovascular system, help us lose weight and get fit. But how does movement help our bones, muscles and joints—also known as the musculoskeletal system?
Why does moving get harder as we age? Can we prevent or slow down the aging process on our bones, muscles and joints?
In your experience, what are the top reasons why people aren’t moving more?
For years we were told to restrict physical activity when we had back pain. Why was that bad advice? How does movement help people heal?
How can people get moving? What are some of the best activities for those who may be largely inactive right now?
Dr. Robert Hayden maintains a private practice in Griffin, Georgia, just south of Atlanta. Dr. Hayden is a past president of the Georgia Chiropractic Association and was named the organization’s "Chiropractor of the Year" in 2006.
Prior to receiving his doctor of chiropractic degree, Dr. Hayden was a cardiovascular clinical nurse specialist. He devoted 18 years to the nursing profession, serving as executive director of the Mississippi Nurses’ Association, and as a registered lobbyist and continuing education consultant.
Dr. Hayden holds bachelor’s degrees in chemistry and nursing, and received his master’s degree in nursing from the University of Alabama. He also holds a PhD from the University of Mississippi and in 1995 received his doctor of chiropractic degree from Life University.
Website: www.acatoday.org
Social Media Links: Facebook: www.facebook.com/acatoday.org Twitter: www.twitter.com/acatodaday

Thursday Sep 27, 2018
Brain U Online, the first scientifically-supported cognitive training program
Thursday Sep 27, 2018
Thursday Sep 27, 2018
Dr. John DenBoer of Smart Brain Aging, a company that has developed Brain U Online - one of the few "digital prescriptions" reimbursable to Medicare and shown to have a very positive effect on the quality of people's lives joins eHealth Radio and the Health News and Mental Health Channels.
Listen to interview with host Eric Michaels and guest Dr. John DenBoer discuss the following:
How did you start your interest in studying Dementia?
Can you explain please how Brain U Online works?
What has been the benefits to Brain U Online in addition to it preventing memory loss and mitigate decline?
Why has Brain U Online become one of the first "Digital Prescriptions" to be covered by Medicare?
What do you see for the future of Brain U Online?
Dr. John DenBoer is a Clinical Neuropsychologist specializing in the assessment and detection of early-stage dementia. He received his internship training at VA Boston Healthcare System (Boston University School of Medicine/Harvard University) and received his postdoctoral training at Barrow Neurological Institute. He has published extensively in the area of Clinical Neuropsychology and has been an expert speaker at many local, national, and international conferences. He is the Founder, CEO, and Chief Medical Officer of SMART Brain Aging, Inc., a company designed to help prevent and intervene in mild cognitive impairment and early-stage dementia.
In the last 3 years he has become a world-renown speaker in the area of early-stage dementia detection and treatment. This has culminated in a Netflix documentary and corresponding book, entitled “This is Dementia?!“.
Websites: www.brainuonline.com | www.smartbrainaging.com
Social Media Links: Facebook: facebook.com/smartbrainaging Twitter: twitter.com/smartbrainaging

Wednesday Sep 19, 2018
Wednesday Sep 19, 2018
Dr. Kavita Mariwalla, a Board Certified Dermatologist and a paid spokesperson for Aclaris Therapeutics & ESKATA joins eHealth Radio and the Dermatology and Health News Channels to talk about the impact of seborrheic keratoses and a new treatment for patients.
Listen to interview with host Eric Michaels and guest Dr. Kavita Mariwalla discuss the following:
What are seborrheic keratoses (SKs) and how do people get them?
What is ESKATA® 40 % hydrogen peroxide topical solution, and how is it used?
What other treatments are available to address SKs?
What did the clinical studies of ESKATA® 40 % hydrogen peroxide topical solution show? What are the benefits and potential side effects?
Why is this new treatment important for your patients?
Dr. Kavita Mariwalla is a nationally recognized leader in dermatology and dermatologic surgery, whose expertise is in the areas of anti-aging procedures and skin cancer treatment.
Prior to starting her own private practice, Dr. Mariwalla was the Director of Cutaneous Oncology at St. Luke’s – Roosevelt and Beth Israel Medical Centers in New York. Dr. Mariwalla has been recognized for extensive work in the area of dermatologic education and is considered an expert injector of fillers and neuromodulators. She has written two editions of the widely used book, “Primer in Dermatologic Surgery,” which is highly regarded by residents and seasoned dermatologic surgeons and is author of the “Cosmeceutical Compendium.” Dr. Mariwalla is editor of “Surgical Pearls” for the Journal of the American Academy of Dermatology and sits on the Board of Directors of the Women’s Dermatologic Society and American Society for Dermatologic Surgery.
In addition, Dr. Mariwalla is noted for sharing her injection techniques during live demonstrations at the American Academy of Dermatology annual meetings. Her private practice has been nominated for the “Best of Long Island,” since its inception in 2012.
Dr. Mariwalla earned her degree in medicine at the Yale School of Medicine where she also completed her dermatology residency and fellowship training.
Websites: www.eskata.com | www.mariwalladermatology.com

Saturday Sep 15, 2018
Curable, The Chronic Pain Self-Help App
Saturday Sep 15, 2018
Saturday Sep 15, 2018
John Gribbin, CEO and Co-Founder of Curable the healthcare technology company to help manage chronic pain joins eHealth Radio and the Pain Management and Technology Channels.
Listen to interview with host Eric Michaels and guest John Gribbin discuss the following:
What is Curable?
Why did you decide to start Curable?
What is a biopsychosocial approach and how does it help with pain relief on the app?
What has been the response from the medical community and the users?
Where do you see Curable headed in the future as a company and as a solution to chronic pain?
John Gribbin is the CEO and a co-founder of Curable. John is an experienced entrepreneur across multiple industries. He is also a former 15-year sufferer of chronic low back pain. Through the treatment method Curable delivers, he was able to completely resolve his pain symptoms and limitations.
Website: www.curablehealth.com
Facebook: www.facebook.com/curablehealth

Wednesday Sep 12, 2018
What to Expect with Psychotherapy
Wednesday Sep 12, 2018
Wednesday Sep 12, 2018
David Collins, from the Toronto-based, Psychotherapy Referral Service that helps over 200 people every year connect with individuals as well as family and couple therapists to help them deal with their emotional and mental health issues joins eHealth Radio and the Health News and Mental Health Channels.
Listen to interview with host Eric Michaels and guest David Collins discuss the following:
There are people out there who may not believe that “talking about your problems to a therapist” will help them in any way. What would you say are the key benefits of therapy?
For people who maybe have never experienced therapy, can you explain basically how psychotherapy works?
What is PRS?
How is professional therapy different from merely talking to friends and family about things that bother you?
What are the indicators that a person should seek therapy?
David Collins is a Registered Psychotherapist that specializes in Emotional Disturbance, Childhood Abuse, Self-Harm, and Gender Issues. He strives to establish a strong rapport so that there hopefully will be nothing too shameful, sorrowful or unnatural, that it cannot be discussed. David believes that unlike our everyday lives, the therapeutic relationship is a unique bubble where we hopefully can feel free of the impingements of society for an hour every week to feel, consider and discuss whatever is our inner truth at the time. If in here we can get beyond the everyday self-censoring, we can engage in a real discussion of issues that may be controlling our lives, but from the shadows beyond our conscious attention.
Website: www.prstoronto.com

Tuesday Sep 11, 2018
Losing hair? We have a safe solution for you, the Theradome
Tuesday Sep 11, 2018
Tuesday Sep 11, 2018
Tamim Hamid, the Inventor of Theradome, the world's most advanced laser hair growth treatment for at home use to stop hair loss and regrow hair joins eHealth Radio and the Hair Health and Health News Channels.
Listen to interview with host Eric Michaels and guest Tamim Hamid discuss the following:
From what I have heard August is Hair Loss Awareness Month... can you tell us a little about this?
Where did the idea to invent Theradome come from?
What is Theradome and why use it?
How does Theradome work?
Besides utilizing Theradome, are there any other strategies or practices you recommend people use to assist with hair loss?
Theradome was founded by a former NASA scientist, Tamim Hamid. Hamid’s educational background consists of a Bachelor of Science in Electrical Engineering, Master of Science in Computer Engineering and a PhD in Biomedical Engineering. Utilizing his edification and his experience, Hamid invented the Theradome laser hair restoration helmet.
The Theradome is a trusted name in clinical-strength hair restoration therapies and is dedicated to developing the world’s most technologically advanced, science-based laser phototherapy hair-growth solutions. To date Theradome’s professional laser phototherapy devices have delivered more than 4,000,000 treatments across 5 continents and are distributed by thousands of hair restoration professionals worldwide. Theradome is a breakthrough technology and we want to make it available and affordable for everyone to use in the comfort and privacy of their home.
Website: https://www.theradome.com Facebook: https://www.facebook.com/Theradome

Thursday Sep 06, 2018
Cariloop and Facebook Join Forces to Provide Support for Working Caregivers
Thursday Sep 06, 2018
Thursday Sep 06, 2018
Michael Walsh, Co-Founder and CEO of Cariloop, a Dallas-based company providing the world’s first fully-integrated, human-powered Caregiver Support Platform to help relieve the stress and anxiety of working caregivers joins eHealth Radio and the Health News Channel.
Listen to interview with host Eric Michaels and guest Michael Walsh discuss the following:
Tell us a little bit about Cariloop and what you are doing with Facebook.
Describe some of the challenges facing working caregivers and how these responsibilities impact work performance.
Why is it in the employer’s best interest to offer caregiver benefits and support?
Are these programs only for larger companies or can other sized organizations support working caregivers?
Are there any other larger companies, other than Facebook, that are moving in this direction to help employees who have to care for loved ones?
Michael Walsh is the Co-founder, Chairman and CEO of Cariloop, a digital health and well-being company based in Dallas, Texas. Since its founding, Michael has helped Cariloop to successfully raise over $3.7 million in private investment capital which has given enabled them to recruit an incredibly passionate team of professionals and assist thousands of caregivers across the US with their life transitions.
Michael and Cariloop have been recognized by Entrepreneur Magazine (Entrepreneur 360), TexChange (One to Watch), Dallas Business Journal (Who’s Who in Healthcare), D Healthcare Daily (Innovation in Medical Technology), Aging 2.0 (Global Startup Search semi-finalist), Tech. co (Startup of the Year semi-finalist) and Becker’s Hospital Review (Healthcare Entrepreneurs to Know).
Michael has also served as the President of the Dallas Roundtable, founded the Dallas chapter of Health 2.0, and a holds a National Academy of Sports Medicine (NASM) Certification in Personal Training (CPT).
He is a 2007 graduate of Purdue University.
About Cariloop
Dallas-based Cariloop provides the world's first fully-integrated, human-powered Caregiver Support Platform to help working caregivers and families plan for and manage the care of their parents, grandparents, spouses, siblings, in-laws, and adult children. The Platform features a HIPAA-compliant, cloud-based application that helps families securely communicate across all devices and store important health, financial, and legal documents while having on-demand access to a dedicated Healthcare Coach who guides the families through the many decisions they make over the length of their caregiving journey.
For more information, visit www.cariloop.com or follow Cariloop on LinkedIn, Twitter and Facebook.
Website: https://www.cariloop.com
Social Media Links: Facebook: https://www.facebook.com/cariloopinc Twitter: https://twitter.com/cariloop